Akcea Therapeutics Inc. (AKCA) Tumbled -8.7% or -2.18 To Price $22.89 On Thursday


Akcea Therapeutics Inc. (AKCA) tumbled -8.7% or -2.18 to $22.89. It is nearly 503871 shares traded, which is 269.59% compare to the average total volume 186903. The market cap of AKCA is $2.12 billion. The year to date change is -27.11%. The 52 week price range is from $18.58 to $40.75. Price of AKCA have changed -1.34% during last week. It have changed -18.05% over last month, -4.71% over last 3 months, -1.65% over last 6 months and 21.35% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AKCA is 28.94. It is 26.43% above current price. The 200-day Moving Averages for AKCA is 29.17. It is 27.44% above current price. The 52-week High is 40.75. It is 78.03% from the current price. The 52-week Low is 18.58. It is -18.83% from current price.

There are some statistics of AKCA. It is has market cap $2.12 billion. The share outstanding is 92.77 million. The average volume is 186903. The percent of top 15 Institution holding is 46.60%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AKCA is -103.26%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AKCA is -72.54%.


Tags:

Share this post